Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Software | 25 | 2023 | 4443 | 2.130 |
Why?
|
Computer Graphics | 7 | 2008 | 361 | 1.290 |
Why?
|
Computational Biology | 17 | 2016 | 3521 | 1.270 |
Why?
|
Gene Expression Profiling | 32 | 2016 | 9438 | 1.020 |
Why?
|
Proteome | 6 | 2023 | 1799 | 1.020 |
Why?
|
Sequence Analysis, DNA | 11 | 2017 | 4803 | 0.950 |
Why?
|
Algorithms | 21 | 2016 | 13881 | 0.800 |
Why?
|
Oligonucleotide Array Sequence Analysis | 18 | 2013 | 3920 | 0.680 |
Why?
|
Information Storage and Retrieval | 7 | 2009 | 824 | 0.660 |
Why?
|
Database Management Systems | 6 | 2009 | 270 | 0.650 |
Why?
|
User-Computer Interface | 9 | 2015 | 1431 | 0.620 |
Why?
|
Databases, Protein | 4 | 2007 | 383 | 0.570 |
Why?
|
Protein Interaction Mapping | 4 | 2007 | 627 | 0.540 |
Why?
|
Flow Cytometry | 6 | 2010 | 5974 | 0.530 |
Why?
|
Models, Biological | 8 | 2012 | 9583 | 0.500 |
Why?
|
Cell Physiological Phenomena | 2 | 2006 | 154 | 0.500 |
Why?
|
Vegetables | 1 | 2020 | 1182 | 0.490 |
Why?
|
RNA Editing | 1 | 2016 | 148 | 0.490 |
Why?
|
Databases, Genetic | 8 | 2013 | 1783 | 0.490 |
Why?
|
Adenosine Deaminase | 1 | 2016 | 241 | 0.470 |
Why?
|
Chromatin Immunoprecipitation | 4 | 2013 | 893 | 0.440 |
Why?
|
Mathematical Concepts | 1 | 2012 | 63 | 0.410 |
Why?
|
Organ Specificity | 2 | 2016 | 2008 | 0.400 |
Why?
|
RNA Splicing | 1 | 2016 | 907 | 0.400 |
Why?
|
Sequence Analysis, RNA | 4 | 2016 | 2012 | 0.390 |
Why?
|
Biometry | 5 | 2010 | 558 | 0.370 |
Why?
|
Models, Genetic | 6 | 2014 | 3494 | 0.370 |
Why?
|
Gene Expression Regulation | 8 | 2016 | 12072 | 0.360 |
Why?
|
High-Throughput Screening Assays | 2 | 2015 | 944 | 0.330 |
Why?
|
Genes, Lethal | 1 | 2008 | 242 | 0.310 |
Why?
|
Chromosome Mapping | 2 | 2006 | 4740 | 0.290 |
Why?
|
Signal Transduction | 8 | 2016 | 23403 | 0.290 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4328 | 0.290 |
Why?
|
Data Mining | 1 | 2012 | 537 | 0.290 |
Why?
|
RNA-Binding Proteins | 1 | 2016 | 1903 | 0.280 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 783 | 0.280 |
Why?
|
RNA | 1 | 2016 | 2749 | 0.270 |
Why?
|
Epistasis, Genetic | 1 | 2008 | 365 | 0.270 |
Why?
|
Saccharomyces cerevisiae | 3 | 2008 | 2752 | 0.270 |
Why?
|
Genomics | 9 | 2017 | 5720 | 0.260 |
Why?
|
Genetics, Population | 2 | 2009 | 934 | 0.260 |
Why?
|
Cell Separation | 3 | 2010 | 1751 | 0.260 |
Why?
|
Models, Statistical | 6 | 2021 | 5102 | 0.250 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2004 | 125 | 0.240 |
Why?
|
Sequence Alignment | 3 | 2013 | 2256 | 0.240 |
Why?
|
Proteins | 3 | 2009 | 6103 | 0.230 |
Why?
|
DNA Probes | 1 | 2004 | 560 | 0.220 |
Why?
|
Diet | 1 | 2020 | 7939 | 0.210 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2013 | 3597 | 0.200 |
Why?
|
Data Interpretation, Statistical | 6 | 2008 | 2716 | 0.200 |
Why?
|
Exons | 3 | 2016 | 2437 | 0.200 |
Why?
|
MyoD Protein | 2 | 2012 | 151 | 0.190 |
Why?
|
Genome, Human | 7 | 2016 | 4420 | 0.180 |
Why?
|
DNA Mutational Analysis | 3 | 2012 | 4186 | 0.180 |
Why?
|
Genome | 3 | 2010 | 1808 | 0.180 |
Why?
|
Databases, Factual | 4 | 2011 | 7729 | 0.180 |
Why?
|
Gene Expression | 4 | 2012 | 7799 | 0.170 |
Why?
|
Terminology as Topic | 1 | 2006 | 1547 | 0.170 |
Why?
|
Alternative Splicing | 2 | 2016 | 1117 | 0.170 |
Why?
|
Computer Simulation | 7 | 2007 | 6196 | 0.170 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2008 | 1888 | 0.160 |
Why?
|
Natural Language Processing | 1 | 2006 | 1041 | 0.160 |
Why?
|
Artifacts | 1 | 2007 | 1904 | 0.160 |
Why?
|
Bayes Theorem | 2 | 2005 | 2309 | 0.150 |
Why?
|
Protein Binding | 3 | 2016 | 9386 | 0.150 |
Why?
|
Transcription Factors | 6 | 2013 | 12208 | 0.140 |
Why?
|
Systems Biology | 3 | 2011 | 469 | 0.140 |
Why?
|
Documentation | 1 | 2003 | 871 | 0.140 |
Why?
|
Transcription, Genetic | 5 | 2016 | 7722 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2016 | 8428 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2012 | 1114 | 0.130 |
Why?
|
Demography | 1 | 2020 | 1656 | 0.130 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 545 | 0.130 |
Why?
|
Base Sequence | 8 | 2014 | 12797 | 0.130 |
Why?
|
Medical History Taking | 2 | 2021 | 783 | 0.130 |
Why?
|
Fruit | 1 | 2020 | 1142 | 0.120 |
Why?
|
Information Dissemination | 4 | 2017 | 1099 | 0.120 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2016 | 377 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2012 | 789 | 0.110 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1660 | 0.110 |
Why?
|
Eating | 1 | 2020 | 1536 | 0.110 |
Why?
|
MicroRNAs | 4 | 2011 | 3752 | 0.110 |
Why?
|
Introns | 1 | 2016 | 991 | 0.110 |
Why?
|
Patient Care | 1 | 2018 | 640 | 0.110 |
Why?
|
Markov Chains | 2 | 2004 | 969 | 0.110 |
Why?
|
Energy Intake | 1 | 2020 | 2148 | 0.110 |
Why?
|
Programming Languages | 2 | 2015 | 133 | 0.100 |
Why?
|
Limonins | 1 | 2012 | 24 | 0.100 |
Why?
|
beta-Defensins | 1 | 2011 | 57 | 0.100 |
Why?
|
Thrombospondins | 1 | 2012 | 197 | 0.100 |
Why?
|
Humans | 43 | 2023 | 744343 | 0.100 |
Why?
|
Muscular Dystrophy, Facioscapulohumeral | 1 | 2011 | 48 | 0.100 |
Why?
|
Reproducibility of Results | 10 | 2016 | 19905 | 0.100 |
Why?
|
Genetic Variation | 1 | 2006 | 6544 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2016 | 1730 | 0.100 |
Why?
|
SOXB1 Transcription Factors | 1 | 2012 | 284 | 0.090 |
Why?
|
Research Design | 1 | 2007 | 5987 | 0.090 |
Why?
|
Proteomics | 2 | 2023 | 3638 | 0.090 |
Why?
|
Quality Control | 3 | 2008 | 841 | 0.090 |
Why?
|
Leukemia, T-Cell | 1 | 2010 | 104 | 0.090 |
Why?
|
Retroelements | 1 | 2011 | 164 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 376 | 0.090 |
Why?
|
HLA-DR Antigens | 2 | 2010 | 645 | 0.090 |
Why?
|
Immunoglobulin A | 1 | 1994 | 992 | 0.090 |
Why?
|
Estrogens | 2 | 2012 | 1566 | 0.090 |
Why?
|
Medical Informatics | 1 | 2017 | 745 | 0.090 |
Why?
|
Leukocyte Count | 1 | 1994 | 1588 | 0.090 |
Why?
|
Gene Amplification | 2 | 2012 | 1063 | 0.090 |
Why?
|
Karyotyping | 3 | 2012 | 1243 | 0.090 |
Why?
|
Muscle Development | 1 | 2012 | 271 | 0.090 |
Why?
|
Virus Integration | 1 | 2012 | 299 | 0.090 |
Why?
|
Epigenomics | 2 | 2012 | 903 | 0.090 |
Why?
|
Urotensins | 1 | 2009 | 7 | 0.090 |
Why?
|
Gene Fusion | 1 | 2012 | 371 | 0.090 |
Why?
|
Cell Line, Tumor | 8 | 2016 | 16689 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2014 | 15519 | 0.080 |
Why?
|
Lung Neoplasms | 5 | 2014 | 13102 | 0.080 |
Why?
|
Bacillus subtilis | 1 | 2012 | 359 | 0.080 |
Why?
|
Hepatitis B virus | 1 | 2012 | 513 | 0.080 |
Why?
|
Leukemia, Lymphoid | 1 | 2008 | 315 | 0.080 |
Why?
|
Likelihood Functions | 1 | 1991 | 1005 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2020 | 3188 | 0.080 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2012 | 388 | 0.080 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2009 | 186 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2014 | 2715 | 0.070 |
Why?
|
Miniaturization | 1 | 2007 | 164 | 0.070 |
Why?
|
Internet | 4 | 2013 | 3064 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2010 | 2942 | 0.070 |
Why?
|
Microarray Analysis | 2 | 2010 | 767 | 0.070 |
Why?
|
Mutation | 7 | 2016 | 29786 | 0.070 |
Why?
|
Software Design | 1 | 2006 | 176 | 0.070 |
Why?
|
Hepatitis B | 1 | 2012 | 695 | 0.070 |
Why?
|
Neuropeptides | 1 | 2012 | 942 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 3 | 2012 | 2849 | 0.070 |
Why?
|
Two-Hybrid System Techniques | 1 | 2007 | 464 | 0.070 |
Why?
|
Epithelium | 1 | 2010 | 1679 | 0.070 |
Why?
|
Binding Sites | 5 | 2012 | 6114 | 0.070 |
Why?
|
Gene Library | 1 | 2008 | 1074 | 0.070 |
Why?
|
Neurogenesis | 1 | 2012 | 838 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3444 | 0.060 |
Why?
|
Chromosomes | 1 | 2008 | 596 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1994 | 2232 | 0.060 |
Why?
|
DNA, Concatenated | 1 | 2004 | 3 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4034 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1676 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4751 | 0.060 |
Why?
|
Point Mutation | 1 | 2010 | 1623 | 0.060 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 170 | 0.060 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2007 | 693 | 0.060 |
Why?
|
Fourier Analysis | 1 | 2005 | 447 | 0.060 |
Why?
|
Molecular Chaperones | 1 | 2008 | 742 | 0.060 |
Why?
|
Hypermedia | 1 | 2003 | 21 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 5221 | 0.060 |
Why?
|
Burkitt Lymphoma | 1 | 2005 | 327 | 0.060 |
Why?
|
Cell Differentiation | 5 | 2012 | 11483 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2012 | 18111 | 0.060 |
Why?
|
Fibrinogen | 1 | 2006 | 894 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2009 | 3505 | 0.060 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2003 | 166 | 0.050 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2004 | 1085 | 0.050 |
Why?
|
Cell Survival | 2 | 2016 | 5882 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25043 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9239 | 0.050 |
Why?
|
Valproic Acid | 1 | 2005 | 445 | 0.050 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2005 | 317 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5510 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2421 | 0.050 |
Why?
|
Hydroxamic Acids | 1 | 2005 | 494 | 0.050 |
Why?
|
Multiprotein Complexes | 1 | 2008 | 1119 | 0.050 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2005 | 651 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 2 | 2012 | 4554 | 0.050 |
Why?
|
Neoplasms | 4 | 2016 | 21683 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1994 | 4386 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2010 | 2072 | 0.050 |
Why?
|
Transplants | 1 | 2003 | 209 | 0.050 |
Why?
|
Drug Discovery | 1 | 2009 | 1058 | 0.050 |
Why?
|
Quantitative Trait Loci | 1 | 2009 | 2019 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2008 | 1294 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2012 | 2541 | 0.050 |
Why?
|
Antigens, CD | 2 | 2010 | 4026 | 0.050 |
Why?
|
DNA-Binding Proteins | 3 | 2012 | 9648 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2012 | 5853 | 0.040 |
Why?
|
DNA Copy Number Variations | 3 | 2012 | 1941 | 0.040 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2005 | 1519 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 2214 | 0.040 |
Why?
|
Escherichia coli | 1 | 2012 | 4217 | 0.040 |
Why?
|
DNA | 1 | 2013 | 7301 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2007 | 2203 | 0.040 |
Why?
|
Probability | 1 | 2005 | 2505 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2005 | 12354 | 0.040 |
Why?
|
Carcinoma, Endometrioid | 1 | 2001 | 271 | 0.040 |
Why?
|
Mice | 7 | 2016 | 81183 | 0.040 |
Why?
|
Muscle, Skeletal | 2 | 2011 | 4931 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2012 | 3848 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5952 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 1 | 2005 | 35421 | 0.040 |
Why?
|
Progesterone | 1 | 2001 | 776 | 0.040 |
Why?
|
Animals | 10 | 2016 | 168757 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2006 | 2416 | 0.040 |
Why?
|
Information Services | 1 | 2017 | 244 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4253 | 0.030 |
Why?
|
Cell Line | 4 | 2013 | 15997 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1060 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2021 | 17446 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2012 | 1783 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 5021 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2005 | 1916 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 2007 | 2957 | 0.030 |
Why?
|
Oncogene Fusion | 1 | 2014 | 99 | 0.030 |
Why?
|
Brain | 2 | 2016 | 26385 | 0.030 |
Why?
|
Adult | 7 | 2021 | 214055 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2005 | 3798 | 0.030 |
Why?
|
Regression Analysis | 3 | 2007 | 6459 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5097 | 0.030 |
Why?
|
Image Enhancement | 1 | 2005 | 2921 | 0.030 |
Why?
|
Homosexuality | 1 | 1994 | 262 | 0.030 |
Why?
|
Phenotype | 2 | 2008 | 16365 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 14722 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2010 | 10180 | 0.030 |
Why?
|
E-Box Elements | 1 | 2012 | 21 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2016 | 13033 | 0.030 |
Why?
|
Bisexuality | 1 | 1994 | 270 | 0.030 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2012 | 154 | 0.030 |
Why?
|
Endometrial Neoplasms | 1 | 2001 | 1353 | 0.030 |
Why?
|
Genes, APC | 1 | 2012 | 159 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2016 | 1526 | 0.030 |
Why?
|
Receptor, erbB-3 | 1 | 2012 | 142 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2012 | 300 | 0.030 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 237 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2012 | 19229 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2012 | 1581 | 0.020 |
Why?
|
Trans-Activators | 2 | 2012 | 2924 | 0.020 |
Why?
|
beta 2-Microglobulin | 1 | 1991 | 315 | 0.020 |
Why?
|
Transcription Initiation Site | 1 | 2011 | 196 | 0.020 |
Why?
|
Insulin-Like Growth Factor II | 1 | 2012 | 271 | 0.020 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2010 | 67 | 0.020 |
Why?
|
Histones | 2 | 2012 | 2599 | 0.020 |
Why?
|
Dioxygenases | 1 | 2012 | 316 | 0.020 |
Why?
|
Myoblasts | 1 | 2011 | 238 | 0.020 |
Why?
|
Fibroblasts | 2 | 2012 | 4161 | 0.020 |
Why?
|
Myocardium | 1 | 2003 | 4776 | 0.020 |
Why?
|
Prostatic Neoplasms | 2 | 2010 | 11124 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5867 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3110 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2007 | 9274 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2012 | 321 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 733 | 0.020 |
Why?
|
Up-Regulation | 2 | 2012 | 4217 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13989 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2010 | 743 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1252 | 0.020 |
Why?
|
Acetylation | 1 | 2012 | 1085 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2011 | 528 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2006 | 20822 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2010 | 345 | 0.020 |
Why?
|
Serum Albumin | 1 | 1991 | 676 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 721 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 1994 | 971 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2012 | 839 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2012 | 670 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9849 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2021 | 12261 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2008 | 255 | 0.020 |
Why?
|
Time Factors | 2 | 2007 | 40075 | 0.020 |
Why?
|
Blood Cells | 1 | 2010 | 309 | 0.020 |
Why?
|
Germ Cells | 1 | 2011 | 631 | 0.020 |
Why?
|
HIV Infections | 1 | 1994 | 16718 | 0.020 |
Why?
|
Ribonucleases | 1 | 2008 | 287 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 936 | 0.020 |
Why?
|
Skin | 1 | 2021 | 4364 | 0.020 |
Why?
|
Multipotent Stem Cells | 1 | 2008 | 186 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 859 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2010 | 555 | 0.020 |
Why?
|
Ribonuclease III | 1 | 2008 | 275 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 1708 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2634 | 0.020 |
Why?
|
Cohort Studies | 1 | 2009 | 40561 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2012 | 1701 | 0.020 |
Why?
|
Heterozygote | 1 | 2012 | 2804 | 0.020 |
Why?
|
Stochastic Processes | 1 | 2007 | 344 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 769 | 0.020 |
Why?
|
Lymph Nodes | 2 | 2010 | 3474 | 0.020 |
Why?
|
Selection, Genetic | 1 | 2010 | 914 | 0.020 |
Why?
|
Protein Kinases | 1 | 2012 | 1640 | 0.020 |
Why?
|
Serine Endopeptidases | 1 | 2010 | 1072 | 0.020 |
Why?
|
Reference Standards | 1 | 2008 | 1025 | 0.020 |
Why?
|
Vocabulary, Controlled | 1 | 2006 | 170 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2005 | 295 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2006 | 411 | 0.020 |
Why?
|
Nucleic Acid Conformation | 1 | 2008 | 913 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2006 | 462 | 0.020 |
Why?
|
Genomic Library | 1 | 2004 | 193 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6171 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2085 | 0.020 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2007 | 502 | 0.010 |
Why?
|
Automation | 1 | 2006 | 584 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2006 | 981 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13695 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5179 | 0.010 |
Why?
|
Rats | 2 | 2008 | 24260 | 0.010 |
Why?
|
Italy | 1 | 2005 | 832 | 0.010 |
Why?
|
Transfection | 1 | 2011 | 5892 | 0.010 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 161 | 0.010 |
Why?
|
Xenopus | 1 | 2005 | 712 | 0.010 |
Why?
|
Middle Aged | 6 | 2021 | 213383 | 0.010 |
Why?
|
Cell Lineage | 1 | 2012 | 2504 | 0.010 |
Why?
|
Host-Pathogen Interactions | 1 | 2012 | 1477 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1991 | 6365 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2008 | 4320 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2007 | 912 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Disease Progression | 2 | 2010 | 13284 | 0.010 |
Why?
|
Antibodies | 1 | 2010 | 2460 | 0.010 |
Why?
|
Male | 7 | 2021 | 350118 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2008 | 795 | 0.010 |
Why?
|
Female | 8 | 2021 | 380194 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 3462 | 0.010 |
Why?
|
Species Specificity | 1 | 2005 | 2478 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2005 | 1880 | 0.010 |
Why?
|
Viruses | 1 | 2004 | 374 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3647 | 0.010 |
Why?
|
Aged | 4 | 2021 | 163280 | 0.010 |
Why?
|
Chromatin | 1 | 2012 | 2934 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2649 | 0.010 |
Why?
|
Carcinoma | 1 | 2011 | 2375 | 0.010 |
Why?
|
DNA Methylation | 1 | 2014 | 4286 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2001 | 431 | 0.010 |
Why?
|
Remission Induction | 1 | 2005 | 2386 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2001 | 802 | 0.010 |
Why?
|
Reference Values | 1 | 2006 | 4982 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2892 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57776 | 0.010 |
Why?
|
Robotics | 1 | 2006 | 899 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2014 | 5172 | 0.010 |
Why?
|
Survival Analysis | 1 | 1992 | 10252 | 0.010 |
Why?
|
Menstrual Cycle | 1 | 2001 | 551 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3617 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11366 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
Cell Communication | 1 | 2003 | 1621 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10481 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11031 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2001 | 1142 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6314 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9727 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2011 | 4838 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13815 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2003 | 6386 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 12951 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 72290 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1991 | 5181 | 0.010 |
Why?
|
Zebrafish | 1 | 2005 | 2994 | 0.010 |
Why?
|
Bacteria | 1 | 2004 | 2114 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 4397 | 0.010 |
Why?
|
Survival Rate | 1 | 2003 | 12788 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15076 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2003 | 21827 | 0.000 |
Why?
|
Inflammation | 1 | 2003 | 10638 | 0.000 |
Why?
|
Adolescent | 1 | 2005 | 85781 | 0.000 |
Why?
|